Blog
RSS FeedPosted by Michael Wonder on 25 May 2022
Medicare spending on drugs with accelerated approval
24 May 2022 - The U.S. FDA provides accelerated approval to drugs on the basis of surrogate end points deemed to ...
Posted by Michael Wonder on 19 Apr 2022
Prioritising reference products over biosimilars led to millions of missed savings for Part D
20 April 2022 - Medicare Part D plans missed out on between $84 million and $143 million in savings by ...
Posted by Michael Wonder on 29 Mar 2022
Budget 2022-23 – no ‘big bang’ announcements in health
29 March 2022 - Medicines Australia welcomes tonight’s Budget announcements for new PBS listings and on-going COVID-19 measures. ...
Posted by Michael Wonder on 29 Mar 2022
Record investment in the future of Australia's health system
29 March 2022 - The Australian Government is investing in a stronger health system as part of our plan for a ...
Posted by Michael Wonder on 19 Mar 2022
Final reconciliation of savings from side agreements for the full year 2021
18 March 2022 - TLV has presented the final reconciliation to the government of the outcome of the rebates in ...
Posted by Michael Wonder on 20 Feb 2022
Stabilising health care’s share of the GDP
19 February 2022 - Since the 1980s, policy makers and private health insurers have implemented various interventions aimed at “bending the ...
Posted by Michael Wonder on 26 Dec 2021
PBS expenditure and prescriptions report 2020-21
24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...
Posted by Michael Wonder on 17 Oct 2021
Recent trends in Medicaid spending and use of drugs with US Food and Drug Administration accelerated approval
8 October 2021 - In this cross-sectional study of 216 drugs granted accelerated approval from 1992 through 2020, relative to all ...
Posted by Michael Wonder on 08 Jul 2021
House report: drug companies spent more on buybacks, dividends than research
8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...
Posted by Michael Wonder on 22 Jun 2021
New drug could cost the Government as much as it spends on NASA
22 June 2021 - The Alzheimer’s treatment will cost $56,000 per patient, and millions may use it. The result: “crazy numbers” ...
Posted by Michael Wonder on 16 Jun 2021
Sweden's cost of medicines is increasing
15 June 2021 - Sweden's costs for pharmaceuticals have risen by approximately SEK 2 billion between 2019 and 2020. ...
Posted by Michael Wonder on 09 May 2021
Protest calls for more drug spending
9 May 2021 - Patients’ rights advocates will lie down on the job, as part of a nationwide day of ...
Posted by Michael Wonder on 25 Mar 2021
High cost patented drugs now account for 50% of sales
25 March 2021 - Federal Minister of Health tables the 2019 Annual Report of the Patented Medicine Prices Review Board ...
Posted by Michael Wonder on 10 Mar 2021
PHARMAC saving money at the expense of Kiwis' health
11 March 2021 - Peter Davis’ observations regarding PHARMAC funding new drugs every time there is a change of government ...
Posted by Michael Wonder on 17 Feb 2021
TLV is tasked with reducing costs for medicines
16 February 2021 - The Government has commissioned the Swedish Dental and Pharmaceutical Benefits Agency, TLV, to implement measures to reduce ...